hsa-miR-519d-3p

ncRNA information

ncRNA name

hsa-miR-519d-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

HCP5

Downstream target

miR-519d/HMGA1

Cancer information

Cancer name

Gastric Cancer

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis

Tissue resource

normal gastric cancer cell lines GES-1

gastric cancer cell lines NCI-N87

gastric cancer cell lines MKN-45

gastric cancer cell lines SNU-1

gastric cancer cell lines KATO-3

Experiment

None


Institute

Shanghai Cell Bank

Country

China

Continent

Asia